UBS Gains as Greensill Settlement and Merger Chatter Offset Swiss Capital Squeeze
Published on 09/26/2026 at 08:30 | Editorial boerse-global.de
UBS shares climbed 2.3% to EUR 43.59 on Friday, lifted by a pair of developments that gave investors something to cheer at the close of a week otherwise dominated by regulatory headwinds from Bern.
The Swiss lender reached a settlement with Australian insurer IAG over claims tied to the collapse of the Greensill supply-chain finance funds — a legal hangover UBS inherited when it absorbed Credit Suisse in an emergency rescue. The total value of the claims originally filed stood at roughly AUD 2.8 billion plus interest, equivalent to about CHF 1.6 billion. The agreement will be booked into the third-quarter 2026 interim report and could carry financial consequences.
Clearing that dispute removes a tangible legal burden from the balance sheet, a development market participants greeted warmly. At the same time, reports of revived merger deliberations injected fresh speculation about the bank's future shape. According to media outlet Semafor, the Swiss giant has reopened discussions about combining with foreign institutions such as Morgan Stanley — a strategic gambit aimed at sidestepping Switzerland's increasingly stringent banking rules.
Parliament Turns the Screw
Those rules took a decisive step forward on Wednesday, when the Swiss Council of States voted 29 to 16 in favor of requiring the big bank to back its foreign subsidiaries with 90% hard core capital (CET1). Reuters characterized the measure as the product of a markedly tougher regulatory climate that has taken shape since Credit Suisse's collapse.
The currency guardians are on board: Swiss National Bank Vice President Antoine Martin said on Thursday that a 90% CET1 backing for UBS's foreign units was appropriate. Higher capital requirements, however, can crimp flexibility and return potential — which is why investors are watching management's response closely.
Should investors sell immediately? Or is it worth buying UBS?
The arithmetic is stark. UBS calculates the 90% rule alone creates an additional CET1 requirement of USD 16 billion. Combined with obligations stemming from the Credit Suisse takeover, the total extra CET1 need reaches roughly USD 33 billion — money that would otherwise fund buybacks or richer dividends. Whether the bank can build that buffer without sacrificing its return targets will shape its valuation for years to come.
Earnings Power as the Counterweight
The optimistic case rests on the franchise's persistent earnings muscle. In the second quarter of 2026, the group posted a net profit of USD 2.8 billion, bringing the half-year result to USD 5.8 billion. Assets under management across the group totaled USD 7.3 trillion.
Wealth management, the crown jewel, keeps expanding reliably. Global Wealth Management drew net new assets of USD 36 billion in the second quarter of 2026, following USD 73 billion across the entire first half. Asset Management chipped in another USD 6 billion in fresh money during the second quarter.
If UBS can keep retiring legal legacies like Greensill while sustaining that inflow momentum, the capital build could be achieved organically — allowing the institution to entrench its global position without resorting to risky mega-deals.
The Competitive Cost of Staying Swiss
The chief danger is a lasting erosion of competitiveness against international rivals. Forcing foreign subsidiaries to hold 90% hard equity makes overseas operations dramatically more expensive. US competitors operate under more flexible frameworks and could seize market share.
Betting on international escape routes carries its own pitfalls. Cross-border bank mergers of this magnitude are considered politically and antitrust-wise extremely difficult to execute. Add to that residual risks from the Credit Suisse integration.
Insider activity has raised eyebrows as well: one executive board member sold 100,000 shares for roughly CHF 4.46 million, while a non-executive director offloaded 75,000 shares worth about CHF 3.32 million. Such transactions counsel caution when sizing up near-term upside.
UBS at a turning point? This analysis reveals what investors need to know now.
Analyst Support and the Road Ahead
Regulatory worries notwithstanding, analyst sentiment provided a tailwind. JPMorgan reaffirmed its "Overweight" rating on UBS on Wednesday with a price target of CHF 50.
CEO Sergio Ermotti, speaking Tuesday at the Bank of America financial conference according to Bloomberg, offered a view on operations: the bank expects third-quarter business development to improve on the prior year. The unusually strong comparable period from 2025, however, is unlikely to be matched.
Technically, as long as the stock holds above its 200-day moving average of EUR 40.46, the broader chart picture remains constructive. Should confidence in the capital plan falter and fears of return-on-equity dilution harden, a fresh slide toward recent annual lows becomes a real possibility.
Investors will get harder numbers soon. UBS plans to publish its third-quarter results on October 28, a report that will for the first time quantify the concrete financial effects of the IAG settlement and reveal how management intends to answer the Council of States' verdict.
Ad
UBS Stock: New Analysis - 26 September
Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
